The Robert Packard Center for ALS Research at Johns Hopkins
Homepage
 


April 28, 2006

PACKARD SCIENTIST DON CLEVELAND JOINS SCIENTIFIC ELITE

This week, Packard researcher Don Cleveland was elected to the National Academy of Sciences, one of the highest honors this country bestows on its scientists. He joins fellow Packard member Rick Huganir, who was inducted last year. To those in the know, joining the NAS marks someone as a scientist’s scientist. Moreover, the 2,000 or so existing Academy members typically select those whose work has social significance or may translate, at some point, into help for humankind.

Packard Scientific Advisor and researcher, Don Cleveland.

Being a member confers some clout. Even from its early days in 1863 when it was established by a federal act signed by Abraham Lincoln, the Academy has advised the government, upon request, in any matter of science or technology. Members may be seen in the halls of Congress; the executive or judicial branches consult them for perspective.

Cleveland, a professor of medicine, neuroscience and cellular and molecular medicine at the University of California, San Diego, heads the Laboratory of Cell Biology at the university’s Ludwig Institute for Cancer Research. And while part of his research there tackles very basic questions on how cells assemble the machinery of mitosis, he’s applied those studies to understanding how ALS works and to finding therapies.

Most recently, he’s shown that motor neuron death in inherited ALS doesn’t necessarily originate in motor neurons — it also requires mutant damage to neighboring supporting cells. This find makes a strong case for the usefulness of stem cell replacement of neighboring cells as an ALS therapy.

And on another front, Cleveland’s work on blocking the handiwork of the mutant SOD1 gene that causes a familial type of ALS — essentially shutting it off before it can damage cells — is being looked into for application, one day, in patients. The approach, called antisense, has lengthened survival of ALS animal models.

Within the Packard community of scientists, Cleveland is well-known, both for the elegance of his research and for his ability to cut to the quick of an experiment’s design. He makes the best sort of devil’s advocate for fellow researchers, often helping them avoid flaws that could bring scientific dead ends. Cleveland’s quick to share models and cultures and equally quick to poke fun at himself. And, as a member of the Packard’s Scientific Advisory Board, he’s both insightful and outspoken, qualities that help keep the Center on track.



>>more Recent News


Recent news from the Robert Packard Center for ALS Research:
William H. Adams Foundation Pumps New Energy, Funds into Search for ALS Cure - May 6, 2008
Tell-Tale Protein Clumping in ALS is Less Complex Than Expected - April 10, 2008

ALS Mouse Study Highlights Astrocytes' Strong Potential as Therapy Target - February 7, 2008

Exciting New Human ALS Trial: Lithium and Riluzole - February 7, 2008
ALS Treatment: A Matter of Cleaning House? - December 19, 2007

New Study Brings What Goes Wrong in Inherited ALS into Focus - September 18, 2007

New ALS Protein Could Be a Keystone - August 9, 2007
Muscles More Than Passive Victims in ALS, Study Suggests - June 29, 2007
Saer and O’Neill Named Packard Center Board Co-Chairs - June 28, 2007

Self-Attack? Self-Repair? First Real Look at Gene Activity in ALS Models Sparks Thirst for Answers - May 3, 2007

Model of Accelerated Familial ALS Sheds Light on Disease Process - April 6, 2007
Early News From First Large Search for Sporadic ALS Genes - February 20, 2007
Human Stem Cell Transplants Mature Into Neurons and Make Contacts in Rat Spinal Cord - February 14, 2007

First Vaccine for Familial ALS Shows Potential in Model Mice - January 29, 2007

Our Five-Year Plan? Let Human Cells EXcellerate Therapy - January 18, 2007




Enter your e-mail address to
join the free ALS News Network!

Johns Hopkins Medicine